Suchergebnisse - "Festen, Eleonora A.M."

  1. 1
  2. 2
  3. 3
  4. 4

    Quelle: Gabriëls, R Y, Van Der Waaij, A M, Linssen, M D, Dobosz, M, Volkmer, P, Jalal, S, Robinson, D, Hermoso, M A, Lub-De Hooge, M N, Festen, E A M, Kats-Ugurlu, G, Dijkstra, G & Nagengast, W B 2024, 'Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease', Gut, vol. 73, no. 9, pp. 1454-1463. https://doi.org/10.1136/gutjnl-2023-331696

    Dateibeschreibung: application/pdf

    Relation: info:eu-repo/semantics/altIdentifier/pmid/38580386; info:eu-repo/semantics/altIdentifier/pissn/0017-5749; info:eu-repo/semantics/altIdentifier/eissn/1468-3288

  5. 5

    Quelle: Hu, S, Bourgonje, A R, Gacesa, R, Jansen, B H, Björk, J R, Bangma, A, Hidding, I J, van Dullemen, H M, Visschedijk, M C, Faber, K N, Dijkstra, G, Harmsen, H J M, Festen, E A M, Vich Vila, A, Spekhorst, L M & Weersma, R K 2024, 'Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease', Nature Communications, vol. 15, 1470. https://doi.org/10.1038/s41467-024-45855-2

    Dateibeschreibung: application/pdf

    Relation: info:eu-repo/semantics/altIdentifier/pmid/38368394; info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/31ba6fe0-135b-4900-85a4-df741c1de975; info:eu-repo/semantics/altIdentifier/pissn/2041-1723; info:eu-repo/semantics/reference/hdl/https://hdl.handle.net/11370/c5cf8818-e3e0-4803-9550-fa86ae6f5753

  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Quelle: Bangma, A, Pibiri, P, Sun, S, De Jong, S, Bigaeva, E, Björk, J R, Karmi, N, Verstappen, G M P J, Kroese, F G M, Kats-Ugurlu, G, Hermoso, M A, Vich Vila, A, van der Wijst, M G P, Faber, K N, Weersma, R K, Uniken Venema, W T C & Festen, E A M 2024 'Inflammatory Bowel Disease in patients with Primary Sclerosing Cholangitis : a distinct form of colitis' MedRxiv. https://doi.org/10.1101/2024.07.23.24310848

  11. 11

    Quelle: J Crohns Colitis

    Dateibeschreibung: application/pdf

  12. 12
  13. 13

    Quelle: Bourgonje, A R, Hu, S, Spekhorst, L M, Zhernakova, D V, Vila, A V, Li, Y, Voskuil, M D, Van Berkel, L A, Folly, B B, Charrout, M, Mahfouz, A, Reinders, M J T, Van Heck, J I P, Joosten, L A B, Visschedijk, M C, Van Dullemen, H M, Faber, K N, Samsom, J N, Festen, E A M, Dijkstra, G & Weersma, R K 2022, 'The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease', Journal of Crohn's and Colitis, vol. 16, no. 3, pp. 414-429. https://doi.org/10.1093/ecco-jcc/jjab157

    Dateibeschreibung: application/pdf

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34491321; info:eu-repo/semantics/altIdentifier/pissn/1873-9946; info:eu-repo/semantics/altIdentifier/eissn/1876-4479

  14. 14

    Quelle: Bourgonje, A R, Bolte, L A, Vranckx, L L C, Spekhorst, L M, Gacesa, R, Hu, S, van Dullemen, H M, Visschedijk, M C, Festen, E A M, Samsom, J N, Dijkstra, G, Weersma, R K & Campmans-Kuijpers, M J E 2022, 'Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease', Nutrients, vol. 14, no. 12, 2522. https://doi.org/10.3390/nu14122522

    Dateibeschreibung: application/pdf

    Relation: info:eu-repo/semantics/altIdentifier/pmid/35745254; info:eu-repo/semantics/altIdentifier/pissn/2072-6643; info:eu-repo/semantics/altIdentifier/eissn/2072-6643

  15. 15

    Quelle: Bourgonje, A R, Wichers, S J, Hu, S, van Dullemen, H M, Visschedijk, M C, Faber, K N, Festen, E A M, Dijkstra, G, Samsom, J N, Weersma, R K & Spekhorst, L M 2022, 'Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease', Scientific Reports, vol. 12, no. 1, 14581. https://doi.org/10.1038/s41598-022-17504-5

    Dateibeschreibung: application/pdf

    Relation: info:eu-repo/semantics/altIdentifier/pmid/36028644; info:eu-repo/semantics/altIdentifier/wos/000846571700023; info:eu-repo/semantics/altIdentifier/pissn/2045-2322

  16. 16

    Quelle: Bourgonje, A R, Alexdóttir, M S, Otten, A T, Loveikyte, R, Bay-Jensen, A-C, Pehrsson, M, van Dullemen, H M, Visschedijk, M C, Festen, E A M, Weersma, R K, Karsdal, M A, Faber, K N, Mortensen, J H & Dijkstra, G 2022, 'Serological biomarkers of type I, III, and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease', Alimentary Pharmacology & Therapeutics, vol. 56, no. 4, pp. 675-693. https://doi.org/10.1111/apt.17063

    Dateibeschreibung: application/pdf

    Relation: info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/b5691308-998b-4876-86ae-1cbd4789d19f; info:eu-repo/semantics/altIdentifier/pissn/0269-2813; info:eu-repo/semantics/altIdentifier/eissn/1365-2036

  17. 17

    Quelle: Alexdottir , M S , Bourgonje , A R , Karsdal , M A , Pehrsson , M , Loveikyte , R , van Dullemen , H M , Visschedijk , M C , Festen , E A M , Weersma , R K , Faber , K N , Dijkstra , G & Mortensen , J H 2022 , ' Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease ' , Frontiers in Medicine , vol. 9 , 933872 . https://doi.org/10.3389/fmed.2022.933872

    Dateibeschreibung: application/pdf

  18. 18
  19. 19

    Quelle: Haisma, S M, Weersma, R K, Joosse, M E, de Koning, B A E, de Meij, T, Koot, B G P, Wolters, V, Norbruis, O, Daly, M J, Stevens, C, Xavier, R J, Koskela, J, Rivas, M A, Visschedijk, M C, Verkade, H J, Barbieri, R, Jansen, D B H, Festen, E A M, van Rheenen, P F & van Diemen, C C 2021, 'Exome sequencing in patient-parent trios suggests new candidate genes for early-onset primary sclerosing cholangitis', Liver International, vol. 41, no. 5, pp. 1044-1057. https://doi.org/10.1111/liv.14831

    Dateibeschreibung: application/pdf

    Relation: info:eu-repo/semantics/altIdentifier/pmid/33590606; info:eu-repo/semantics/altIdentifier/pissn/1478-3223; info:eu-repo/semantics/altIdentifier/eissn/1478-3231

  20. 20